Covid-19 Delta variant resulting in multi system thromboembolic disease
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2022/09/01
-
Indian UGC (journal)
-
Refrences23
-
Citations4
-
Gabriella Fluss
-
Victoria Cranwell
-
Ajit Rao
-
Joon Sub Lee ORCID (unauthenticated)
-
Ramy Elshafey
-
Marc Wallack
-
David Finlay ORCID (unauthenticated)
Cite
Fluss, Gabriella, et al. “Covid-19 Delta Variant Resulting in Multi System Thromboembolic Disease”. Annals of Vascular Surgery - Brief Reports and Innovations, vol. 2, no. 3, 2022, p. 100101, https://doi.org/10.1016/j.avsurg.2022.100101.
Fluss, G., Cranwell, V., Rao, A., Lee, J. S., Elshafey, R., Wallack, M., & Finlay, D. (2022). Covid-19 Delta variant resulting in multi system thromboembolic disease. Annals of Vascular Surgery - Brief Reports and Innovations, 2(3), 100101. https://doi.org/10.1016/j.avsurg.2022.100101
Fluss, Gabriella, Victoria Cranwell, Ajit Rao, Joon Sub Lee, Ramy Elshafey, Marc Wallack, and David Finlay. “Covid-19 Delta Variant Resulting in Multi System Thromboembolic Disease”. Annals of Vascular Surgery - Brief Reports and Innovations 2, no. 3 (2022): 100101. https://doi.org/10.1016/j.avsurg.2022.100101.
Fluss G, Cranwell V, Rao A, Lee JS, Elshafey R, Wallack M, et al. Covid-19 Delta variant resulting in multi system thromboembolic disease. Annals of Vascular Surgery - Brief Reports and Innovations. 2022;2(3):100101.
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Multisystem assessment of the imaging manifestations of coagulopathy in hospitalized patients with coronavirus disease (COVID-19) | 2021 | |||
| Aortic thrombus in patients with severe COVID-19: review of three cases | Journal of Thrombosis and Thrombolysis |
| 22 | 2021 |
COVID‐19‐related coagulopathy: A review of pathophysiology and pharmaceutical management | Cell Biology International |
| 23 | 2021 |
| SARS-CoV-2 and limb ischemia: A systematic review | Journal of Clinical Orthopaedics and Trauma | 18 | 2021 | |
| Multisystem thromboembolism in a COVID-19 patient: a case report | Journal of Community Hospital Internal Medicine Perspectives |
| 3 | 2021 |
Refrences Analysis
The category
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system 15
is the most frequently represented among the references in this article. It primarily includes studies from Cell Biology International and British Journal of Haematology. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Aspirin/enoxaparin sodium/heparin | Reactions Weekly | 2023 | ||
Acute Renal Vein Thrombosis Following COVID-19 in a Lupus Patient: A Case Report and Review of the Literature | Life |
| 2023 | |
SARS-CoV-2 RBD and Its Variants Can Induce Platelet Activation and Clearance: Implications for Antibody Therapy and Vaccinations against COVID-19 | Research |
| 3 | 2023 |
Pathogenesis and histological changes of nephropathy associated with COVID‐19 | Journal of Medical Virology |
| 5 | 2022 |
Citations Analysis
The category
Science 2
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Pathogenesis and histological changes of nephropathy associated with COVID‐19 and was published in 2022. The most recent citation comes from a 2023 study titled Aspirin/enoxaparin sodium/heparin. This article reached its peak citation in 2023, with 3 citations. It has been cited in 4 different journals, 50% of which are open access. Among related journals, the Reactions Weekly cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.